Advances in understanding and treating ADHD
KM Antshel, TM Hargrave, M Simonescu, P Kaul… - BMC medicine, 2011 - Springer
Attention deficit hyperactivity disorder (ADHD) is a neurocognitive behavioral developmental
disorder most commonly seen in childhood and adolescence, which often extends to the …
disorder most commonly seen in childhood and adolescence, which often extends to the …
Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder
Children, adolescents and adults with attention-deficit/hyperactivity disorder (ADHD)
experience functional impairment and poor health-related quality of life (HRQoL) in addition …
experience functional impairment and poor health-related quality of life (HRQoL) in addition …
Development of three web-based computerized versions of the kiddie schedule for affective disorders and schizophrenia child psychiatric diagnostic interview …
L Townsend, K Kobak, C Kearney, M Milham… - Journal of the American …, 2020 - Elsevier
Objective To present initial validity data on three web-based computerized versions of the
Kiddie Schedule for Affective Disorders and Schizophrenia (KSADS-COMP). Method The …
Kiddie Schedule for Affective Disorders and Schizophrenia (KSADS-COMP). Method The …
Efficacy and safety of atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: results from a comprehensive meta-analysis and …
S Schwartz, CU Correll - Journal of the American Academy of Child & …, 2014 - Elsevier
Objective To comprehensively evaluate the efficacy and safety of atomoxetine (ATX) in
pediatric attention-deficit/hyperactivity disorder (ADHD). Method Meta-analysis of all double …
pediatric attention-deficit/hyperactivity disorder (ADHD). Method Meta-analysis of all double …
The safety of atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a comprehensive review of over a decade of …
VA Reed, JK Buitelaar, E Anand, KA Day, T Treuer… - CNS drugs, 2016 - Springer
Atomoxetine is a noradrenergic reuptake inhibitor prescribed for attention-
deficit/hyperactivity disorder (ADHD) that first gained approval in the USA in 2002 and has …
deficit/hyperactivity disorder (ADHD) that first gained approval in the USA in 2002 and has …
Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in …
M Stuhec, B Munda, V Svab, I Locatelli - Journal of affective disorders, 2015 - Elsevier
Objectives There is a lack of comparative effectiveness research among attention deficit
hyperactivity disorder (ADHD) drugs in terms of efficacy and acceptability, where bupropion …
hyperactivity disorder (ADHD) drugs in terms of efficacy and acceptability, where bupropion …
Pharmacotherapy of attention-deficit hyperactivity disorder in adolescents
AC Childress, SA Berry - Drugs, 2012 - Springer
Attention-deficit hyperactivity disorder (ADHD) is a common neurobehavioural disorder in
children and adolescents, consisting of developmentally inappropriate levels of inattention …
children and adolescents, consisting of developmentally inappropriate levels of inattention …
Psychopharmacological treatment of disruptive behavior in youths: Systematic review and network meta-analysis
To conduct a systematic review of the comparative efficacy of various psychotropic
medications for the treatment of disruptive behavior (DBs) in youths. To this aim, we …
medications for the treatment of disruptive behavior (DBs) in youths. To this aim, we …
Efficacy and safety of medication for attention-deficit hyperactivity disorder in children and adolescents with common comorbidities: a systematic review
Introduction Comorbid psychiatric conditions in children and adolescents with attention-
deficit hyperactivity disorder (ADHD) occur frequently, complicate management, and are …
deficit hyperactivity disorder (ADHD) occur frequently, complicate management, and are …
A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities
DB Clemow, C Bushe, M Mancini… - Neuropsychiatric …, 2017 - Taylor & Francis
Attention-deficit hyperactivity disorder (ADHD) is a common neuropsychiatric disorder that is
often diagnosed during childhood, but has also increasingly been recognized to occur in …
often diagnosed during childhood, but has also increasingly been recognized to occur in …